Ondřej Fiala

Diagnostic exome sequencing in early‐onset Parkinson's disease confirms <i>VPS13C</i> as a rare cause of autosomal‐recessive Parkinson's disease

Barbara Schormair, David Kemlink, Brit Mollenhauer et al. · Clinical Genetics · 2017 · 91 citations · Full text

Genetic Testing, Exome Sequencing, Genetics +18

The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer

Ondřej Fiala, Miloš Pešek, Jindřich Fínek et al. · Cancer Genetics · 2013 · 61 citations

Oncology, Cell Lung Cancer, Medicine +8

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib

Ondřej Fiala, Miloš Pešek, Jindřich Fínek et al. · Neoplasma · 2016 · 61 citations · Full text

Serum Albumin, Pretreatment Serum Albumin, Medicine +15

Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy

Hong Xu, Thomas W. Rösler, Thomas Carlsson et al. · Current Gene Therapy · 2014 · 54 citations

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

Ondřej Fiala, Tomáš Büchler, Beatrice Mohelníková-Duchoňová et al. · Tumor Biology · 2015 · 54 citations